Companies and Brands
Samsung Biologics
Health Care
Citation Formats
General Reference
APA Style
BibTeX
Samsung Biologics is a South Korean contract development and manufacturing organization headquartered in Songdo, Incheon. Established in 2011 as the biotechnology division of Samsung Group, it manufactures biologic drugs for pharmaceutical partners, from late stage drug development through large scale commercial production, with a focus on monoclonal antibodies, bispecific antibodies, antibody drug conjugates and mRNA vaccines. Its client roster includes major pharmaceutical companies such as Pfizer, GlaxoSmithKline, Eli Lilly, AstraZeneca and Bristol Myers Squibb. As of 2025 the company employed about 5,300 people and reported 2024 revenue of 4.55 trillion South Korean won with operating income of 325.7 billion won.
Sources
Reader Challenges (0 open reader challenges)
No disputes yet. Spotted an error or a better source? Open the first one.
Sign in to dispute this or suggest a correction.
View At A Past Year
The atlas records no dated fact of its own for this entry, so there is no other year to choose.